Heng Xie
Keine laufenden Positionen mehr
Karriereverlauf von Heng Xie
Ehemalige bekannte Positionen von Heng Xie
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
 Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 01.03.2022 | 01.06.2022 |
| Unternehmenssekretär | 01.06.2022 | - |
Ausbildung von Heng Xie
| The University of Alabama at Birmingham | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 2 |
| China | 2 |
Operativ
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
| Corporate Secretary | 1 |
Sektoral
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Health Technology |
